New therapies in development for autoimmune diseases: their rationale for combination treatment

  • Vibeke Strand
  • Published 2001 in Springer Seminars in Immunopathology


Over the past decade, combination therapy has emerged as the preferred treatment for severe as well as early aggressive rheumatoid arthritis (RA). This therapeutic approach has been driven by recognition that RA is not only debilitating disease with significant morbidity, but that it can cause premature mortality. Even though methotrexate (MTX) has become a… (More)
DOI: 10.1007/s002810100071


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.

Slides referencing similar topics